18 Nov 2024
// PR NEWSWIRE
30 Oct 2024
// PRESS RELEASE
29 Oct 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
01 3ASENAPINE MALEATE
02 2ASPIRIN; BUTALBITAL; CAFFEINE
03 1ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
04 2BRIMONIDINE TARTRATE
05 2CHLORAMPHENICOL
06 1CHLORAMPHENICOL; PREDNISOLONE
07 1CROMOLYN SODIUM
08 1CYCLOSPORINE
09 1DEXAMETHASONE
10 2DICYCLOMINE HYDROCHLORIDE
11 3DILTIAZEM HYDROCHLORIDE
12 1DIPIVEFRIN HYDROCHLORIDE
13 1EPINASTINE HYDROCHLORIDE
14 1ESTRADIOL
15 4ETHINYL ESTRADIOL; NORETHINDRONE
16 1ETHOXZOLAMIDE
17 1FERRIC OXYHYDROXIDE
18 4FLUOCINOLONE ACETONIDE
19 1FLUOROMETHOLONE
20 1FLUOROMETHOLONE; SULFACETAMIDE SODIUM
21 1FLURBIPROFEN SODIUM
22 1GATIFLOXACIN
23 1GENTAMICIN SULFATE
24 2GENTAMICIN SULFATE; PREDNISOLONE ACETATE
25 5HYDROCORTISONE
26 2HYDROXYPROGESTERONE CAPROATE
27 1IDOXURIDINE
28 1KETOROLAC TROMETHAMINE
29 2LEVOBUNOLOL HYDROCHLORIDE
30 6LIOTRIX (T4;T3)
31 1MEDRYSONE
32 1MEMANTINE HYDROCHLORIDE
33 12MORPHINE SULFATE
34 1NAPHAZOLINE HYDROCHLORIDE
35 4NEBIVOLOL HYDROCHLORIDE
36 1NEDOCROMIL SODIUM
37 1NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE
38 1OFLOXACIN
39 2OXYBUTYNIN
40 5OnabotulinumtoxinA
41 1PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE
42 1PODOFILOX
43 1POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE
44 2PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
45 2PROGESTERONE
46 1PROPARACAINE HYDROCHLORIDE
47 1SELENIUM SULFIDE
48 2SILODOSIN
49 3SULFACETAMIDE SODIUM
50 5TAZAROTENE
51 2TRETINOIN
52 1TRIAMCINOLONE ACETONIDE
53 3TRIMEPRAZINE TARTRATE
54 2TROSPIUM CHLORIDE
55 2URSODIOL
01 2AEROSOL;TOPICAL
02 17CAPSULE, EXTENDED RELEASE;ORAL
03 5CAPSULE;ORAL
04 7CREAM;TOPICAL
05 1CREAM;VAGINAL
06 1EMULSION; OPHTHALMIC
07 1FILM, EXTENDED RELEASE;TRANSDERMAL
08 1GEL, METERED;TRANSDERMAL
09 5GEL;TOPICAL
10 2GEL;VAGINAL
11 3INJECTABLE;INJECTION
12 1INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
13 1LOTION/SHAMPOO;TOPICAL
14 6OINTMENT;OPHTHALMIC
15 2OINTMENT;TOPICAL
16 21SOLUTION/DROPS;OPHTHALMIC
17 1SOLUTION;ORAL
18 2SOLUTION;TOPICAL
19 3SUSPENSION/DROPS;OPHTHALMIC
20 2SUSPENSION;OPHTHALMIC
21 1SYRUP;ORAL
22 17TABLET;ORAL
23 2TABLET;ORAL-21
24 2TABLET;ORAL-28
25 3TABLET;SUBLINGUAL
26 5VIAL; SINGLE-USE
01 20.01%
02 10.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
03 10.0125MG;0.0031MG
04 30.025%
05 10.025MG;0.0063MG
06 10.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 20.035MG;0.5MG
08 20.035MG;1MG
09 10.0375%
10 30.05%
11 10.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
12 10.05MG;0.0125MG
13 10.075%
14 60.1%
15 10.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
16 10.1%;10%
17 10.12%;0.1%
18 10.15MG;0.0375MG
19 10.1MG;0.025MG
20 10.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
21 20.2%;10%
22 10.25% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 10.25MG;0.0625MG
24 20.3%
25 60.5%
26 10.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
27 51%
28 11%;0.5%
29 210%
30 110,000 UNITS/ML;EQ 1MG BASE/ML
31 2100 UNITS/VIAL
32 1100MG
33 110MG
34 110MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
36 1125MG
37 1125MG/ML
38 1130MG
39 1150MG
40 1180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 22.5%
43 1200 UNITS/VIAL
44 1200MG
45 120MG
46 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
47 1240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
48 1250MG
49 1250MG/ML
50 12MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 13%
52 13.9MG/24HR
53 130%
54 130MG
55 2325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1325MG;50MG;40MG;30MG
57 14%
58 14% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
59 140MG
60 14MG
61 250 UNITS/VIAL
62 1500MG
63 150MG
64 160MG
65 160MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 170MG
67 18%
68 180MG
69 18MG
70 18MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
71 1EQ 0.3% BASE
72 1EQ 0.3% BASE;0.6%
73 1EQ 0.3% BASE;1%
74 1EQ 0.35% BASE;10,000 UNITS/ML;0.5%
75 1EQ 100MG IRON/2ML (EQ 50MG IRON/ML)
76 2EQ 10MG BASE
77 3EQ 2.5MG BASE
78 1EQ 2.5MG BASE/5ML
79 1EQ 20MG BASE
80 3EQ 5MG BASE
01 84DISCN
02 24RX
03 6Blank
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : CHLOROPTIC S.O.P.
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 61187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LOOKING FOR A SUPPLIER?